Авторы

  • Ачилова Д.Н.
  • Элмуродова А.А.

Ключевые слова:

гепатит Д - гепатит В – эпидемиология - цирроз печени – фиброгенез.

Библиографические ссылки

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J. Hepatol. 2012; 57:167–185.

Abdurahmanov D.T., Hronicheskiy gepatit V i D (Chronic hepatitis B and D), M., GEOTAR Media, 2010; 288 p.

Rizzetto M., Alessia C. Epidemiology of Hepatitis D. Semin. Liver. Dis. 2012; 32:211–219.

Kaliaskarova K.S. Faktoryi progressirovaniya hronicheskih virusnyih gepatitov V, S v korennoy populyatsii Kazahstana : avtoreferat dis. d-ra med. nauk - Karaganda, 2010; 24 p.

Degertekin H, Yalçin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int. 2008; 28(4):494-8.

Nersesov A.V., i dr . Rasprostranennost virusnyih gepatitov sredi zhiteley Yuzhno-Kazahstanskoy oblasti (The prevalence of viral hepatitis among residents of the South Kazakhstan region), Medicine (Almaty). 2016; 9(171):30-33.

Hazanov A.I., Vasilev A.P., Pehtashev S.G. i dr. Znachenie osnovnyih i dobavochnyih etiologicheskih faktorov v razvitii HBV- i HCV-tsirrozov pecheni (The importance of the main and additional etiological factors in the development of HBV and HCV cirrhosis), Ros. zhurn. gastroenterol. gepatol. koloproktl. 2001; 4:8-12

Amosov A. D., Gepatit V: inform.-metod. Posobie, A. D. Amosov. M., 2006; pp. 100-103.

Kaliaskarova K.S., Primenenie Pegintrona pri 1b genotipe hronicheskogo gepatita S u kazahov (The use of Pegintron at 1b genotype of chronic hepatitis C in Kazakhs), Meditsinskiy vestnik Severnogo Kavkaza, 2008; 3:13-14.

Rizzetto M. Hepatitis D: Thirty years after. J. Hepatol. 2009; 50:1043–1050.

Wedemeyer H., Manns M. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat. Rev. Gastroenterol. Hepatol. 2010; 7:31.

Wedemeyer H., Yurdaydin C., Dalekos G. et al. Peginterferon plus Adefovir versus either drug alone for hepatitis delta. NEJM. 201; 364:322–331.

Rizzetto M, Niro GA. Myrcludex B, a novel therapy for chronic hepatitis D?. Journal of hepatology. 2016 Sep 1; 65(3): 465-6.

Shahgildyan I.V i dr., Epidemiologicheskie zakonomernosti i sovremennyie podhodyi k vaktsinoprofilaktike gepatita B (Epidemiological patterns and modern approaches to the vaccine prophylaxis of hepatitis B), Gepatologiya. 2003; 2:4 – 10.

Ivashkin, V.T., Kletochnaya i molekulyarnaya biologiya vospaleniya pecheni (Cellular and molecular biology of liver inflammation), Ros. zhurn. gastroenterologii, gepatologii, koloproktologii. 1998; 5:13-17.

Bueverov, A.O., Immunologicheskie mehanizmyi povrezhdeniya pecheni (Immunological mechanisms of liver damage), Ros. zhurn. gastroenterologii, gepatologii, koloproktologii. 1998; 5:18-21.